US going through rough patch but promising launches ahead Despite a challenging time, US remains a key driver for the company, contributing ~42% to total revenues. The company has a strong pending pipeline comprising 104 (58 Para IV filings, 34 FTFs) and three NDAs under 505 (b)(2) route. We expect US sales to grow at a CAGR of 11% to | 7395...